CGAS and neoplasm: To test whether the cGas/STING pathway contributed to the observed genotype-specific effects on drug responses, we generated two independent shRNAs capable of suppressing cGas expression (SI Appendix, Fig. S4D), transduced these into MPB1 tumor cells, and examined their impact on senescence and tumor phenotypes following cisplatin treatment.